Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.57B |
| 2 |
Microsoft
MSFT
|
+$1.4B |
| 3 |
NVIDIA
NVDA
|
+$1.36B |
| 4 |
Amazon
AMZN
|
+$1.19B |
| 5 |
Broadcom
AVGO
|
+$1.13B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
WRK
WestRock Company
WRK
|
+$316M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$187M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
+$159M |
| 4 |
ETRN
Equitrans Midstream Corporation Common Stock
ETRN
|
+$139M |
| 5 |
Cadence Design Systems
CDNS
|
+$113M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.03% |
| 2 | Financials | 12.84% |
| 3 | Healthcare | 11.54% |
| 4 | Consumer Discretionary | 10.45% |
| 5 | Industrials | 8.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1801
CRA International
CRAI
$1.06B
| $28.3M | ﹤0.01% |
161,208
+1,559
| +1% | +$260K |
|
1802
Scansource
SCSC
$1.12B
| $28.1M | ﹤0.01% |
585,072
-12,858
| -2% | -$609K |
|
1803
Central Garden & Pet Co Class A
CENTA
$2.44B
| $28M | ﹤0.01% |
892,314
-5,690
| -0.6% | -$189K |
|
1804
Avis
CAR
$5.02B
| $27.9M | ﹤0.01% |
319,022
-7,578
| -2% | -$684K |
|
1805
Klaviyo
KVYO
$4.73B
| $27.8M | ﹤0.01% |
786,186
+244,447
| +45% | +$7.09M |
|
1806
Employers Holdings
EIG
$889M
| $27.8M | ﹤0.01% |
579,404
+3,349
| +0.6% | +$155K |
|
|
TPC
1807
Tutor Perini Cor
TPC
$5.21B
| $27.8M | ﹤0.01% |
1,023,198
+38,458
| +4% | +$879K |
|
1808
AdaptHealth
AHCO
$759M
| $27.5M | ﹤0.01% |
2,451,173
+265,712
| +12% | +$2.82M |
|
1809
Tarsus Pharmaceuticals
TARS
$2.84B
| $27.5M | ﹤0.01% |
835,790
+62,555
| +8% | +$1.76M |
|
1810
Utz Brands
UTZ
$1.25B
| $27.4M | ﹤0.01% |
1,548,231
+47,320
| +3% | +$786K |
|
1811
Delek US
DK
$3.58B
| $27.4M | ﹤0.01% |
1,459,301
+63,502
| +5% | +$1.34M |
|
1812
Kaiser Aluminum
KALU
$3.02B
| $27.3M | ﹤0.01% |
376,745
+4,388
| +1% | +$338K |
|
|
CSR
1813
Centerspace
CSR
$952M
| $27.3M | ﹤0.01% |
387,517
+11,749
| +3% | +$845K |
|
1814
German American Bancorp
GABC
$1.9B
| $27.3M | ﹤0.01% |
704,094
+11,386
| +2% | +$437K |
|
|
SLNO
1815
DELISTED
Soleno Therapeutics
SLNO
| $27.3M | ﹤0.01% |
540,296
+51,189
| +10% | +$2.45M |
|
1816
Winmark
WINA
$1.32B
| $27.3M | ﹤0.01% |
71,185
+1,445
| +2% | +$537K |
|
1817
Agilon Health
AGL
$1.6B
| $27.1M | ﹤0.01% |
275,741
+3,396
| +1% | +$439K |
|
1818
Sphere Entertainment
SPHR
$5.73B
| $27.1M | ﹤0.01% |
613,008
+7,434
| +1% | +$320K |
|
|
ZUO
1819
DELISTED
Zuora, Inc.
ZUO
| $27M | ﹤0.01% |
3,137,007
+119,439
| +4% | +$1.06M |
|
1820
Encore Capital Group
ECPG
$2.13B
| $27M | ﹤0.01% |
570,047
+13,648
| +2% | +$648K |
|
|
HUT
1821
Hut 8
HUT
$10.9B
| $26.9M | ﹤0.01% |
2,193,900
+381,720
| +21% | +$5.08M |
|
|
ACH
1822
Accendra Health
ACH
$214M
| $26.9M | ﹤0.01% |
1,711,453
+13,164
| +0.8% | +$199K |
|
1823
Ferrovial N.V. Ordinary Shares
FER
$47.9B
| $26.8M | ﹤0.01% |
627,308
-910
| -0.1% | -$37.2K |
|
1824
Arlo Technologies
ARLO
$1.65B
| $26.6M | ﹤0.01% |
2,192,273
+48,221
| +2% | +$638K |
|
1825
Barrett Business Services
BBSI
$804M
| $26.5M | ﹤0.01% |
705,598
+32,632
| +5% | +$1.15M |
|
Similar funds
Geode Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Geode Capital Management held 4,685 positions worth $1.23T, up 8.4% from $1.14T the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Geode Capital Management's Q3 2024 filing shows 98 new, 3,266 increased, 979 reduced and 150 closed positions. Its largest new stake was Smurfit Westrock: 12,733,113 shares worth $627M. The largest sale was WestRock Company, an estimated $316M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Financials and Healthcare.
- Geode Capital Management's largest Q3 2024 buy was Smurfit Westrock: 12,733,113 shares worth $627M.
- Geode Capital Management added most to Apple in Q3 2024, an estimated $4.57B increase.
- Geode Capital Management's biggest Q3 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $187M.
- Geode Capital Management fully exited WestRock Company in Q3 2024, selling an estimated $316M.
- Geode Capital Management's ten largest holdings make up 30% of its $1.23T portfolio in Q3 2024.
- Geode Capital Management opened 98 new positions and closed 150 in Q3 2024.
- Geode Capital Management's portfolio value rose 8.4% quarter-over-quarter to $1.23T.
Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.